CHEK1 and cancer: To further determine whether there existed difference of the activation of DNA damage checkpoint responses between radioresistant cancer cells and parental cells, we examined the expression levels of activating phosphorylated Chk1, Chk2, cdc25C, and ATRIP by western blotting after IR treatment.